Effect of oral administration of Methylene Blue MMX tablets on double-stranded DNA damage assessed by γH2AX analysis of colon biopsy samples.

Trial Profile

Effect of oral administration of Methylene Blue MMX tablets on double-stranded DNA damage assessed by γH2AX analysis of colon biopsy samples.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jan 2016

At a glance

  • Drugs Methylthioninium chloride-Cosmo (Primary)
  • Indications Colon cancer
  • Focus Pharmacodynamics
  • Sponsors Cosmo Pharmaceuticals
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 31 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTtrials.gov.
    • 11 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top